Results 51 to 60 of about 649 (95)

Finding the right tool for the specific task: navigating RWE tools and checklists. [PDF]

Future Oncol
Willke R, Cottu P, Briggs A, Siebert U, Chen C, Korytowsky B, Heidt J, Renfrow M, Lovett K, Brufsky A.   +9 more
europepmc   +1 more source

Secukinumab in active lupus nephritis: results from a phase III randomized, placebo-controlled study (SELUNE) and an open-label extension study. [PDF]

Rheumatology (Oxford)
Zhao MH, Cons Molina F, Aroca G, Tektonidou MG, Mathur A, Tangadpalli R, Sun R, Martin R, Pellet P, Ngoc Phuong Huynh T.   +9 more
europepmc   +1 more source

Characteristics, treatment patterns, healthcare resource use, and costs among adult patients diagnosed with neurofibromatosis type 1 and plexiform neurofibromas in the United States. [PDF]

BMC Neurol
Yang X, Obeng-Kusi M, Dettling T, Adeyemi A, Cunnington M, Liu Q, Lejeune D, Chen G, Duh MS, Jordan JT.   +9 more
europepmc   +1 more source

Impact of Delaying Disease Recurrence on Economic Burden in Patients with HER2+ Early-Stage Breast Cancer (eBC). [PDF]

Clinicoecon Outcomes Res
Princic N, Faherty E, Moynihan M, Henriques C, Mehta S.   +4 more
europepmc   +1 more source

Exploration of utilizing electronic health databases in evidence-based practice among Iranian pharmacists: a survey by simulation of health-seeking pregnant women. [PDF]

J Pharm Health Care Sci
Pourbala H, Mohammadnezhad G, Esmaily H.
europepmc   +1 more source

Bridging the Gap in the Clinical Application of Advanced Parenteral Nutrition Formulations: From Efficacy to Real-World Challenges. [PDF]

Adv Nutr
Zhao M, Zhao X, Zhou Y, Zhang J, Zhou L, Zuo S, Xu G, Bian X, Zhu Y.   +8 more
europepmc   +1 more source

Characteristics, treatment patterns, healthcare resource utilization, and costs in patients with eosinophilic esophagitis in the United States: a retrospective analysis of insurance claims data. [PDF]

Ther Adv Gastroenterol
Xu X, Maslova E, Kielar D, Stirnadel-Farrant H, Meyers J, Chehade M, Katial R, Chen SY.   +7 more
europepmc   +1 more source

Coexisting Type 2 Inflammatory Conditions in Patients with Asthma Treated with Dupilumab: the RAPID Registry. [PDF]

Adv Ther
Peters AT, Côté A, Muñoz X, Xia C, Nash S, Hardin M, de Prado Gómez L, Sacks HJ, Jacob-Nara JA, Rowe PJ, Deniz Y.   +10 more
europepmc   +1 more source

Substandard medicines in Nepal: a crisis of access, equity, and a call for action. [PDF]

Front Public Health
Ghimire A.
europepmc   +1 more source

Initial Real-World Evidence for Lecanemab in the United States. [PDF]

Drugs Aging
Brixner DI, Zhao C, Toyosaki H, Frech FH, Rosenbloom MH.   +4 more
europepmc   +1 more source